ELMD Electromed, Inc. ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Best Electromedical Stocks 2026 →

Electromed (ELMD) Stock: Buy, Sell, or Hold?

$24.97
+0.01 (+0.04%) ▲
5d: -6.72% 30d: -9.13% 90d: -39.42%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (57%)
Quality Score
44/100
Position
OVERSOLD
30-Day Fair Range
$26.41 – $28.02
Position: OVERSOLD
Forward P/E & Valuation
16.9x CHEAP
vs 22.5x historical avg
Wall Street Target
$48.50
+94.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$23.64 / $28.12
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELMD shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When ELMD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$60.35
Based on 12.8% avg growth
INTRINSIC VALUE TODAY
$37.47
33.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ELMD is currently trading at $24.97, which is considered oversold relative to its 30-day fair value range of $26.41 to $28.02. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.9) compared to its historical average (22.5). Remarkably, the market is currently pricing in an annual earnings decline of 9.2% over the next few years. This pessimistic expectation contrasts with the company's recent 28.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, ELMD is in a strong downtrend. Immediate support is located at $23.64, while resistance sits at $28.12.

Market Sentiment: ELMD scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $48.50 (+94.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $26.41 - $28.02
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Trading Range & Key Levels

30-Day Trading Range $26.41 - $28.02
Current vs Trading Range OVERSOLD
Support Level $23.64
Resistance Level $28.12
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Protect Your Profits

Holding ELMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (34/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 94.2% below Wall St target ($48.50)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 16.87
Wall Street Target $48.50 (+94.2%)
Revenue Growth (YoY) 10.6%
Earnings Growth (YoY) 28.0%
Profit Margin 15.8%
Valuation Discount vs History -9.2% cheaper
PE vs Historical 16.9 vs 22.5 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -9.2% (market-implied from PE analysis)
1-Year Target $22.67 (-9%)
2-Year Target $20.59 (-18%)
3-Year Target $18.69 (-25%)
3-Yr Target (if PE normalizes) (PE: 17→23) $24.93 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 21.6%) $52.90 (+112%)
Base: (SPY PE: 16.9, Growth: 21.6%) $44.94 (+80%)
Bear: (PE: 14.3, Growth: 21.6%) $38.20 (+53%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 20.91 | Current EPS (TTM): $1.30
Bull Case $34.04 (+36%)
Analyst growth 13.8%, PE expands to 23.0
Base Case $30.94 (+24%)
Market implied 13.8%, PE stable at 20.9
Bear Case $18.48 (-26%)
Severe decline -20.0%, PE contracts to 17.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.9 to 22.5
Stabilization Target: $33.30 (+33.4%)
PE Expansion Potential: +33.4%
Share ELMD Analysis

Share this live ELMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ELMD)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 2, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits is currently flooded with neutral to bullish sentiment towards $ELMD, with no significant news articles available.
Key Retail Themes: Trader optimism Lack of news impact
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 5:52 PM ET
Data refreshes hourly during market hours. Next update: 6:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ELMD.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DXCM
DexCom Inc
STRONG BUY
29 analysts
$98 54 HOLD
SYK
Stryker Corporation
STRONG BUY
30 analysts
$340 45 HOLD
ABT
Abbott Laboratories
STRONG BUY
28 analysts
$119 48 HOLD
BSX
Boston Scientific Corp
BUY
31 analysts
$50 51 HOLD
EW
Edwards Lifesciences Corp
STRONG BUY
30 analysts
$112 33 SELL

Advanced ELMD Option Strategies

Professional options setups generated by AI based on today's ELMD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ELMD Research Pages
ELMD Technical Chart ELMD Price Prediction ELMD Intrinsic Value DCF ELMD Earnings Date ELMD Investment Advisor ELMD Fair Price Analyzer ELMD Options Chain ELMD Options Advisor ELMD Options Analysis ELMD Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals